Table 1.

Usage of the TCR V-β Families Tested in Peripheral Blood CD8^+bright and CD4⁺ T Cells from Normal Healthy Adult Individuals (n = 10)

TCR-Vβ families	% CD8+bright T cells			% CD4+ T cells			P value
Vβ1.1 (BV1S1)	3.5	3.5 ± 1.2	(1.4–5.3)	3.0	3.0 ± 0.5	(2.1–3.8)	N.S.
Vβ2.1 (BV2S1)	4.4	4.7 ± 1.5	(3.0–6.7)	9.6	9.6 ± 0.9	(8.1–11.2)	.0001
Vβ3.1 (BV3S1)	4.3	4.4 ± 3.5	(0.7–11.4)	4.3	4.8 ± 2.3	(1.3–7.3)	N.S.
Vβ5.1 (BV5S1)	2.7	3.0 ± 1.2	(1.7–5.8)	6.5	6.6 ± 1.0	(5.0–8.3)	.0001
Vβ5.2 (BV5S2)	0.3	0.3 ± 0.2	(0.1–0.7)	0.5	0.4 ± 0.1	(0.3–0.6)	N.S.
Vβ5.3 (BV5S3)	0.8	0.9 ± 0.4	(0.5–1.8)	1.2	1.2 ± 0.3	(0.8–1.8)	.030
Vβ6.1 (BV6S1)	0.2	0.2 ± 0.2	(0.0–0.8)	0.3	0.4 ± 0.2	(0.1–0.9)	N.S.
Vβ6.7 (BV6S7)	1.1	1.4 ± 0.9	(0.7–3.7)	3.4	4.0 ± 1.8	(1.5–7.0)	.003
Vβ7.1 (BV7S1)	3.1	3.3 ± 1.8	(0.9–7.5)	2.0	1.9 ± 0.3	(1.4–2.4)	.030
Vβ8.1+8.2 (BV8S1+S2)	2.9	3.4 ± 1.7	(1.9–7.6)	3.8	3.8 ± 0.6	(2.8–4.7)	N.S.
Vβ9.1 (BV9S1)	2.2	2.5 ± 1.3	(1.1–5.4)	1.9	2.0 ± 0.8	(0.7–3.0)	N.S.
Vβ11.1 (BV11S1)	0.3	0.8 ± 1.6	(0.1–5.3)	0.6	0.5 ± 0.2	(0.2–0.8)	N.S.
Vβ12.2 (BV12S2)	1.1	1.0 ± 0.4	(0.2–1.4)	1.6	1.5 ± 0.3	(0.9–2.0)	.008
Vβ13.1 (BV13S1)	1.3	1.2 ± 0.6	(0.2–1.99)	3.0	2.8 ± 1.2	(0.6–4.7)	.003
Vβ13.6 (BV13S6)	1.4	1.4 ± 0.6	(0.6–2.3)	1.8	1.6 ± 0.2	(1.1–1.8)	N.S.
Vβ14.1 (BV14S1)	1.5	1.6 ± 1.1	(0.4–3.7)	0.9	0.9 ± 0.5	(0.3–2.0)	N.S.
Vβ16.1 (BV16S1)	0.6	1.3 ± 1.4	(0.4–4.9)	0.9	0.9 ± 0.2	(0.7–1.2)	N.S.
Vβ17.1 (BV17S1)	3.8	4.7 ± 2.4	(2.1–9.3)	5.6	5.5 ± 0.9	(4.4–7.1)	N.S.
Vβ18.1 (BV18S1)	0.1	0.1 ± 0.1	(0.0–0.3)	0.4	0.5 ± 0.6	(0.1–2.3)	.040
Vβ20.1 (BV20S1)	1.6	1.6 ± 0.9	(0.5–2.8)	2.9	2.6 ± 1.1	(1.0–4.3)	.048
Vβ21.3 (BV21S3)	2.7	2.7 ± 0.6	(1.7–3.5)	2.3	2.4 ± 0.5	(1.8–3.3)	N.S.
Vβ22.1 (BV22S1)	2.5	2.4 ± 0.6	(1.1–3.6)	2.9	3.1 ± 0.9	(2.3–4.9)	.046
Vβ23.1 (BV23S1)	0.6	0.7 ± 0.3	(0.4–1.1)	0.6	0.6 ± 0.2	(0.2–0.8)	N.S.
Total	47.8	46.1 ± 5.6	(37.4–53.5)	61.3	60.3 ± 4.3	(53.3–65.5)	–

Results are presented as median values (bold), mean ± standard deviation, and range (minimum-maximum).